scholarly journals Risk and Protective Factors in the Origin of Atrial Septal Defect Secundum - National Population-Based Case-Control Study

2014 ◽  
Vol 22 (1) ◽  
pp. 42-47
Author(s):  
Melinda Csáky-Szunyogh ◽  
Attila Vereczkey ◽  
Róbert Urbán ◽  
Andrew E. Czeizel
Keyword(s):  
Protective Factors ◽  
Atrial Septal Defect ◽  
Septal Defect ◽  
Case Control Study ◽  
Risk And Protective Factors ◽  
Population Based ◽  
Case Control ◽  
National Population ◽  
Control Study

scholarly journals Risk and protective factors of self-immolation: a population based case control study from Iran

2012 ◽  
Vol 18 (Suppl 1) ◽  
pp. A165.1-A165 ◽  
Author(s):  
Alireza Ahmadi ◽  
Reza Mohammadi ◽  
Afshin Almasi ◽  
Homayoun Sadeghi-Bazargani ◽  
Shahrzad Bazargan-Hejazi
Keyword(s):  
Protective Factors ◽  
Case Control Study ◽  
Risk And Protective Factors ◽  
Population Based ◽  
Case Control ◽  
Self Immolation ◽  
Control Study

Risk and protective factors in the origin of conotruncal defects of heart-a population-based case-control study

2013 ◽  
pp. n/a-n/a ◽  
Author(s):  
Melinda Csáky-Szunyogh ◽  
Attila Vereczkey ◽  
Zsolt Kósa ◽  
Balázs Gerencsér ◽  
Andrew E. Czeizel
Keyword(s):  
Protective Factors ◽  
Case Control Study ◽  
Risk And Protective Factors ◽  
Population Based ◽  
Case Control ◽  
Control Study

Birth outcomes of cases with isolated atrial septal defect type II - a population-based case-control study

2013 ◽  
Vol 92 (7) ◽  
pp. 824-829 ◽  
Author(s):  
Attila Vereczkey ◽  
Zsolt Kósa ◽  
Melinda Csáky-Szunyogh ◽  
Róbert Urbán ◽  
Andrew E. Czeizel
Keyword(s):  
Atrial Septal Defect ◽  
Birth Outcomes ◽  
Septal Defect ◽  
Case Control Study ◽  
Population Based ◽  
Case Control ◽  
Type Ii ◽  
Defect Type ◽  
Control Study

scholarly journals NSAID consumption and risk of acute myeloid leukemia: a national population-based case-control study

2018 ◽  
Vol Volume 10 ◽  
pp. 5043-5051 ◽  
Author(s):  
Lene Østgård ◽  
Mette Nørgaard ◽  
Lars Pedersen ◽  
René Østgård ◽  
Lone Friis ◽  
...  
Keyword(s):  
Acute Myeloid Leukemia ◽  
Myeloid Leukemia ◽  
Case Control Study ◽  
Population Based ◽  
Case Control ◽  
National Population ◽  
Nsaid Consumption ◽  
Control Study ◽  
Acute Myeloid

scholarly journals Maternal use of cough medications during early pregnancy and selected birth defects: a US multisite, case–control study

BMJ Open ◽  
2021 ◽  
Vol 11 (12) ◽  
pp. e053604
Author(s):  
Yanyan Cao ◽  
Anthony Rhoads ◽  
Trudy Burns ◽  
Ryan M Carnahan ◽  
Kristin M Conway ◽  
...  
Keyword(s):  
Birth Defects ◽  
Septal Defect ◽  
Case Control Study ◽  
Intestinal Atresia ◽  
Population Based ◽  
Atrioventricular Septal Defect ◽  
Case Control ◽  
Small Intestinal ◽  
Limb Deficiency ◽  
Control Study

ObjectiveTo examine associations between maternal use of cough medications containing dextromethorphan (DM) without guaifenesin (glyceryl guaiacolate (GG)) (‘DM alone’), GG without DM (‘GG alone’) or DM +GG and major birth defects in offspring.DesignPopulation-based case–control study.SettingThe multisite, US National Birth Defects Prevention Study.ParticipantsMothers of 1644 children with neural tube defects (NTDs), 15 110 with non-NTDs, and 10 671 control children without a birth defect diagnosis.Main outcome measuresORs and 95% CIs.ResultsFor NTD analysis, 1.7% of mothers of case children and 1.2% of mothers of control children reported using DM alone, 1.1% and 0.6% GG alone, and 0.4% and 0.2% DM +GG. Respective percentages for non-NTD analysis were 2.2% and 1.9% for DM alone, 1.7% and 1.6% for GG alone, and 0.5% and 0.4% for DM +GG. For all NTDs and subtypes, adjusted OR estimates for DM alone were near the null with 95% CIs that included 1.0. Estimates (95% CI) were 1.8 (1.0 to 3.3) for GG alone and 1.8 (0.6 to 4.8) for DM +GG with all NTDs and 2.2 (1.1 to 4.3) for GG alone with spina bifida. Of the 45 adjusted OR estimates for non-NTDs, 39 ranged from 0.5 to 1.6 with 95% CIs that included 1.0. Near twofold or higher estimates (95% CI) were observed for the remainder and included 1.9 (1.0 to 3.7) for hydrocephalus, 2.9 (1.3 to 6.5) for atrioventricular septal defect and 1.8 (1.1 to 3.0) for transverse limb deficiency with DM alone; 2.1 (1.1 to 4.0) for small intestinal atresia/stenosis and 2.1 (0.9 to 4.5) for omphalocele with GG alone; and 3.2 (1.5 to 6.9) for gastroschisis with DM +GG.ConclusionsMaternal use of medications containing DM alone, GG alone or DM +GG showed positive associations with a small number of birth defects. These observations, which should be interpreted with caution due to small proportions of exposed mothers, may represent true signals or chance findings and warrant evaluation in future studies.

Risk and protective factors for midgut carcinoid tumors: Multicenter case-control study of prospectively evaluated patients.

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. e14533-e14533
Author(s):  
M. Rinzivillo ◽  
G. Capurso ◽  
D. Campana ◽  
N. Fazio ◽  
F. Panzuto ◽  
...  
Keyword(s):  
Protective Factors ◽  
Case Control Study ◽  
Risk And Protective Factors ◽  
Case Control ◽  
Carcinoid Tumors ◽  
Midgut Carcinoid ◽  
Control Study
Sign in / Sign up

Export Citation Format

Share Document